Development of an Intervention and and Education Program for Adult Women With Urinary Incontinence and Chronic Lung Disease Including Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)
Sponsor study identifier
Secondary identifiers
interventional
99
1 country
2
Study Start
December 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2004
Actual (reported)Study Completion
June 2004
Actual (reported)Women with chronic lung disease characterised by chronic cough report urinary incontinence. Recently there have been reports of increased urinary incontinence in girls and women with cystic fibrosis. While coughing is a known risk factor for stress incontinence, other risk factors and causes are poorly understood in this population. Treatment of incontinence for patients with chronic lung disease is also poorly addressed, adding to the burden of disease for women with chronic lung disease, carers and the health system. This project will estimate the prevalence of women with CF and COPD compared to healthy age matched controls and will evaluate the effect of a specific treatment and management program for these patients. The results will be disseminated to respiratory health professionals. We hypothesise that women with chronic cough will have a higher incidence of urinary incontinence than healthy controls and that a specific treatment program will result in alleviation of the problems and improved quality of life.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2004
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2001
Date type not reportedThis date has not been verified as actual or estimated.
June 2004
Actual (reported)June 2004
Actual (reported)September 13, 2005
Actual (reported)September 14, 2005
Actual (reported)Symptom measures:
3-day frequency volume chart,
24 hour pad weigh test,
accident diary,
quality of life using King's Health Questionnaire.
pelvic floor muscle function:
Trans-abdominal diagnostic ultra-sound
EMG study of the pelvic floor muscles
Pelvic floor training, biofeedback.
pelvic floor training, electrotherapy, bladder retraining.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
School of Physiotherapy, The University of Melbourne
Melbourne, Victoria, 3052, Australia
Brenda M Button, DPhty, PhD
The Alfred
John W Wilson, MBBS, PhD
The Alfred
99 participants (actual enrollment reported by the registry).
First Submitted
September 13, 2005
First Posted
September 14, 2005
Study Start
December 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2004
Actual (reported)Study Completion
June 2004
Actual (reported)Last Updated
November 28, 2013
Record last verified: 2005-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: